abstract
B
racing is a mainstay of treatment for adolescent idiopathic scoliosis (AIS) mid-range curves. Although full-time bracing has the longest history, concern with compliance 1,2 and negative psychosocial effects of daytime bracing 3 have led to the study of part-time bracing protocols. 4, 5 Success with part-time protocols has been associated with more aggressive braces designed solely for nighttime use. 6 These braces allow for greater in-brace curve corrections than standard thoracolumbosacral orthoses and are typically worn for 8 to 10 hours per day. Two wellknown designs are the Charleston brace and the Providence brace. The Charleston brace is a side-bending orthosis designed to hold the patient in an overcorrected position compared with traditional braces. [7] [8] [9] [10] [11] [12] [13] The Providence brace, a more recent design, was introduced by d'Amato et al 14 and uses controlled lateral and derotational forces on the trunk to move the spine toward or beyond the midline to gain curve correction. 15, 16 There has been a lack of uniformity among studies of bracing outcomes in defining inclusion criteria and standardizing outcomes. 17 For example, as a greater understanding of the natural history of AIS developed, patients who were most at risk for curve progression were better identified, and those less at risk were excluded. Patients who were skeletally mature at initiation of bracing, those with curves so small that progression was unlikely, and those with curves so large that nonoperative treatment would be ineffective were more often excluded. The studies continued to lack a set of objective, standardized inclusion criteria. In addition, the outcomes measured by studies have varied greatly. Different studies have considered treatment a success only if curve progression does not exceed 5° at skeletal maturity, only if curve progression does not exceed 10° at skeletal maturity, only if the curve is less than 45° at skeletal maturity, or only if surgery was not necessary, regardless of the amount of curve progression. This variation in inclusion criteria and outcomes makes it extremely difficult to compare the results of treatment across studies and brace types. As a result, in 2005, Richards et al, 17 in conjunction with a committee of the Scoliosis Research Society (SRS), published a set of standard inclusion criteria and outcomes to be used in future bracing studies.
To date, there are only 3 studies in the literature reporting the clinical outcomes of Providence bracing of AIS patients. [14] [15] [16] Two of these studies were conducted prior to the publication of SRS criteria for standardization of bracing studies, [14] [15] whereas only 1 was conducted after and adheres to the criteria. 16 The current study reports the authors' experience with this nighttime bracing system compared with the published data on the natural history of AIS, the published data on other braces, and the limited clinical data on the Providence brace to date. Importantly, the study adheres to SRS criteria for standardization of bracing studies, with 2 modifications, as described here.
Materials and Methods
The authors conducted a retrospective cohort study with the approval of the institutional review board. Through a review of medical records, the authors identified all patients treated with the Providence brace between 2003 and 2008 by a senior author (P.A.D.). Further inclusion criteria were based on the SRS criteria for standardization of bracing studies. 17 These include an initial age of 10 years or older, initial Risser stage between 0 and 2, initial Cobb angle between 25° and 40°, no prior treatment, no secondary diagnosis, and, if female, either initially premenarchal or less than 1 year postmenarchal. Scoliosis Research Society criteria also require that patients without progression be followed until 2 years after skeletal maturity to ensure nonprogression. To accommodate the local practice of scoliosis bracing, the criteria were extended to include curves of 20° or greater that had been braced after observation of progression as well as a minimum follow-up of 1 year after brace discontinuation or skeletal maturity.
Patients were instructed to wear the brace for a minimum of 8 hours while sleeping each night. As part of routine practice, at the first follow-up visit after bracing was prescribed, a posteroanterior prone radiograph was taken to calculate percent correction of the curve in the brace and to make adjustments to the brace as needed. At subsequent follow-up visits, standing posteroanterior radiographs out of the brace were taken to assess curve magnitude. Bracing was continued until skeletal maturity as determined by Risser stage 4 or higher, no axial growth over 2 visits 6 months apart, or at least 18 months postmenses. Patients were then followed at regular intervals after brace discontinuation to assess for any further curve progression. Demographic, clinical, and radiographic data were collected by review of patient charts and radiographs. Patient charts were reviewed for comments regarding noncompliance. Any patient who had a comment suggesting noncompliance in his or her chart was categorized as noncompliant; all other patients were categorized as compliant.
Outcomes were as established by SRS criteria for standardization of bracing studies. The primary outcome was progression more than 5° at skeletal maturity. Secondary outcomes were progression to more than 45° at skeletal maturity and recommendation for or performance of surgical fusion.
Data were analyzed using STATA version 11.2 statistical software (StataCorp, College Station, Texas). Statistical analyses were performed using Pearson's chi-square test. Statistical difference was established at a 2-sided ß level of 0.05 (P<.05).
results
Eighty-nine patients were initially identified as having been treated with the Providence brace. There were 16 exclusions due to age younger than 10 years, 5 due to a Risser stage higher than 2, 9 due to prior treatment, 3 due to secondary diagnoses, and 22 due to insufficient follow-up. As a result, 34 patients met inclusion criteria and constituted the study population. Demographics of the study population are shown in Table 1 . Average patient age was 12.9 years, average initial Cobb angle was 27°, and average curve correction in the brace was 90%.
Seventeen (50%) patients progressed more than 5°, and 9 (26%) patients progressed to more than 45° and also had fusion surgery recommended or performed ( Table 2) .
Ten (29%) patients were categorized as noncompliant. Patients who progressed more than 5° were no more and no less likely than those who did not to be categorized as noncompliant (P=.132; Table 3 ). However, patients who progressed to more than 45° were more likely than those who did not to be categorized as noncompliant (56% vs 20%; P=.045). Similarly, because they were the same patients, patients who had fusion surgery recommended or performed were also more likely than those who did not to be categorized as noncompliant (56% vs 20%; P=.045).
Mean Cobb angles at brace initiation and latest follow-up are shown in Table  4 . Rates of progression more than 5° are stratified by demographic variable in Table 5. Boys had a higher rate of progression more than 5° than did girls (100% vs 41%; P=.015).
Finally, the authors conducted 2 separate analyses of the rate of progression more than 5°, each among a different subset of the population of 34 patients. The purpose of these 2 separate analyses was to analyze 2 populations of patients similar to those used in 2 natural history studies 18, 19 for appropriate comparison with the authors' results to theirs. Criteria for inclusion in the subset for comparison to Lonstein and Carlson 18 were those of their own study plus a Cobb angle between 20° and 29° and Risser stage between 0 and 1 at brace initiation. When the authors applied these additional inclusion criteria to their study population, that population fell to 21 patients, and the rate of progression more than 5° was 67%. This can be comn Feature Article pared with the rate of progression more than 5° of 68% observed by Lonstein and Carlson. 18 Similarly, criteria for inclusion in the subset for comparison to Nachemson and Peterson 19 were those of their own study plus female patients and a Cobb angle of 25° to 35° at brace initiation. When they applied these additional inclusion criteria to the authors' study population, that population fell to 22 patients, and the rate of progression more than 5° was 41%. This can be compared with the rate of progression more than 5° of 66% observed by Nachemson and Peterson.
discussion
Bracing is a mainstay of treatment for AIS, and in recent years, interest in braces designed to be worn only part time has increased.
1-6 One such brace, the Providence brace, is being used with increasing frequency despite limited literature evaluating its ability to alter the natural course of disease. The current study is only the fourth [14] [15] [16] to describe outcomes of bracing with the Providence brace and only the second 16 to do so using SRS criteria for standardization of bracing studies. 17 Overall, half of the patients in the current study progressed more than 5°, and approximately a quarter of the patients progressed to more than 45°, and that same quarter of patients had fusion surgery recommended or performed. This was accomplished with an average inbrace curve correction of 90%. Although noncompliance was not associated with progression more than 5°, it was associated with progression to more than 45° and having fusion surgery recommended or performed. And among demographic variables, progression more than 5° was more likely only with variable of male sex.
The first studies to report outcomes of nighttime Providence bracing were conducted by d'Amato et al 14 and Yrjonen et al. 15 Both were prospective studies conducted before publication of SRS criteria. 17 The studies had rates of progression more than 5° of 26% and 27%, respectively, which are somewhat lower than the current study's rate of 50%. These rates were accomplished with average inbrace curve corrections of 96% and 92%, respectively, which are similar to the current study's average correction of 90%. The difference between the reported rates of progression and the current study's rate of progression most likely lies in the different inclusion criteria used by the earlier studies. Perhaps most importantly, the new SRS inclusion criteria require analyses to be based on intent to treat. Whereas the current study conformed to this requirement, including noncompliant patients in the analysis, d'Amato et al 14 and Yrjonen et al 15 did not. The third study of outcomes of bracing with the Providence brace was conducted by Janicki et al. 16 It was a retrospective study of 35 patients and used inclusion criteria similar to those used in the current study, including not excluding noncompliant patients. These authors reported a rate of progression more than 5° of 69%, somewhat higher than the rate of progression in the current study. Although the difference in rates of progression between these 2 studies may reflect real differences based on patient population or physician practice, given the similarly modest sample sizes of both studies, it is also possible that the difference is the result of random error.
The outcomes of Providence bracing in these 4 studies can be compared with the more extensive literature on the outcomes of part-time bracing with the Charleston brace. [7] [8] [9] [10] [11] [12] [13] These studies show rates of progression more than 5° ranging from 17% to 57%, which encompasses the current study's rate of progression of 50%. This reported range of progression rates was achieved with a Charleston brace with average in-brace curve corrections from 70% to 87%, somewhat less than in the current study. Of note, none of these studies adhered to SRS criteria for standardization of bracing studies.
The outcomes can also be compared with the literature on Boston bracing. Although the Boston brace is worn full time, it only achieves approximately 50% inbrace curve correction. Reported Boston bracing rates of progression more than 5° range from 18% to 69%, 8, [20] [21] [22] [23] which includes the current study's rate for the Providence brace. Only 1 of these studies adhered to modified SRS criteria. 23 That study, the BRAIST randomized controlled trial, reported an intent-to-treat rate of bracing failure of 25% (defined by curve progression to 50° or more). Unfortunately, it did not report a specific rate of progression more than 5° and so cannot be directly compared with the current study.
Finally, the current authors can compare outcomes of bracing studies with natural history data presented in earlier studies. Among patients with Risser stage between 0 and 1 and a curve magnitude between 20° and 29°, Lonstein and Carlson 18 reported a 68% rate of progression more than 5°. When the current study is restricted to this same subset of patients (21 patients), the rate of progression is 67%. These 2 rates are similar, failing to provide evidence for the Providence brace's efficacy. However, among females with curves between 25° and 35°, Nachemson and Peterson 19 reported a 66% rate of progression more than 5°. When the current study is restricted to this same subset of patients (22 patients), the rate of progression is 41%, lower than that observed in natural history, supporting the Providence brace's efficacy.
In the current study, patients who progressed to more than 45° had a higher rate of noncompliance compared with patients who did not progress to more than 45°. Compliance has been shown to correlate with brace success, and methods have been designed to objectively measure brace compliance.
1,2,22 Many studies cite the potential of part-time braces to improve compliance rates and therefore improve success rates. However, compliance rates have not been objectively monitored in any of the nighttime brace studies to date (including the current study). Some of these studies neglect to report compliance-subjective or otherwise-altogether. This is an area for future research.
Limitations of the current study include its retrospective nature, lack of randomization, and lack of a control group. Also, there was only a subjective assessment of compliance, relying on patient or caregiver reporting in clinic notes rather than on more objective means. Expectancy bias or confirmation bias could have led to disproportionate documentation of noncompliance by the senior author; that is, there could have been a natural cognitive bias in the setting of failed brace wear/progression to surgery, leading to increased documentation of noncompliance in these cases. Finally, the authors had a substantial number of initially identified patients who had insufficient follow-up and had to be excluded from the analysis.
conclusion
This study is only the second study of outcomes of Providence bracing to be based on SRS criteria for standardization of bracing studies. The somewhat higher rates of progression more than 5° reported in these 2 studies compared with those reported in earlier studies likely result from this distinction. This study suggests a rate of progression that is similar to or lower than rates reported in natural history studies, possibly supporting the efficacy of the Providence brace. Additional studies using SRS criteria, including high-quality randomized, controlled trials, will be important to further understanding the relative effectiveness of this and other bracing protocols. In particular, future prospective studies should include an objective assessment of compliance using a validated method such as a temperature sensor, which allows calculation of a dose response, where the dose is hours worn per day.
1,2, 22 In addition to simple measures of compliance, attention to the psychosocial effect of nighttime vs full-time bracing as a secondary outcome of a prospective trial would also be useful to clinicians. The methods used in the BRAIST randomized, controlled trial of the Boston brace 23 are now the gold standard for bracing trials. Those authors enrolled both a randomized cohort and a preference cohort, and their conclusions were based both on as-treated (with propensity score adjustment) and intent-to-treat analyses. These dual analyses, along with the demonstration of a convincing dose-response curve, give their study great strength and conn Feature Article
